Mansoor Raza Mirza
Mansoor Raza Mirza is a Chief Oncologist at the Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. He obtained his M.D. degree in clinical oncology. He was the President-Elect of the Nordic Society of Gynaecologic Oncology (NSGO). He also occupied the posts of Medical Director at the NSGO-Clinical Trial Unit and Vice Chairman of the Danish Gynaecological Center Society (DGCG). He is a Member of the Faculty at European Society of Medical Oncology (ESMO), a Member of the Faculty at Dow University of Health Sciences (DUHS), Karachi, Pakistan, a Member of the Board of Directors at Metamark Genetics Inc., Boston, and a Member of the Board of Directors at Karyopharm Therapeutics Inc., Boston. His area of expertise includes gynecologic oncology. Being both Medical and Radiation Oncologist and having main interest in gynaecologic oncology, Dr. Mirza is involved in nonsurgical treatment of gynaecologic cancers, working in a multidisciplinary oncology and surgical team within the largest university hospital of Denmark. His key academic goals are to promote clinical research, international trial collaboration, and education. He has been a National Coordinator and Principal Investigator of multiple phase 3 clinical trials in gynaecologic cancer for more than a decade. He represents DGCG in the European Network of Gynaecologic Oncology Trials (ENGOT) and NSGO in the Gynaecologic Cancer Inter-Group (GCIG).
Biography Updated on 14 March 2013